Thromb Haemost 1979; 42(04): 1135-1140
DOI: 10.1055/s-0038-1657008
Symposium on Oral Anticoagulant Control
Schattauer GmbH Stuttgart

The Stability of the WHO Reference Thromboplastin NIBS & C 67/40

G I C Ingram
The Department of Haematology, St. Thomas’ Hospital London SEI 7EH, England
› Author Affiliations
Further Information

Publication History

Publication Date:
23 August 2018 (online)

Summary

The International Reference Preparation of human brain thromboplastin coded 67/40 has been thought to show evidence of instability. The evidence is discussed and is not thought to be strong; but it is suggested that it would be wise to replace 67/40 with a new preparation of human brain, both for this reason and because 67/40 is in a form (like Thrombotest) in which few workers seem to use human brain. A �plain� preparation would be more appropriate; and a freeze-dried sample of BCT is recommended as the successor preparation. The opportunity should be taken also to replace the corresponding ox and rabbit preparations. In the collaborative study which would be required it would then be desirable to test in parallel the three old and the three new preparations. The relative sensitivities of the old preparations could be compared with those found in earlier studies to obtain further evidence on the stability of 67/40; if stability were confirmed, the new preparations should be calibrated against it, but if not, the new human material should receive a calibration constant of 1.0 and the new ox and rabbit materials calibrated against that.

The types of evidence available for monitoring the long-term stability of a thromboplastin are discussed.

 
  • References

  • 1 Bangham DR, Biggs R, Brozoviń M, Denson KW E. 1970. Draft report of a collaborative study of two thromboplastins (including the use of common abnormal plasma). In: Roller F, Brinkhous KM, Biggs R, Rodman NF, Hinnom S. (eds.) Vascular Factors and Thrombosis. F. K. Schattauer Verlag, Stuttgart; New York: Thrombosis et Diathesis Haemorrhagica Suppl. 40 p 341
  • 2 Bangham DR, Biggs R, Brozoviń M, Denson KW E. 1973; Calibration of five different thromboplastins, using fresh and freeze-dried plasma. Thrombosis et Diathesis Haemorrhagica 29: 228
  • 3 Bangham DR, Loeliger EA. 1977; Stability of reference thromboplastins. Lancet 2: 1280
  • 4 Denson KW E. 1961; An investigation of Thrombotest and the preparation of a similar combined reagent. Journal of Medical Laboratory Technology 18: 257
  • 5 Denson KW E. 1969. Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy. In: Owren PA, Brinkhous KM. eds Proceedings of the International Committee on Thrombosis and Haemostasis. Washington, D. C: 12/1967. F. K. Schattauer Verlag, Stuttgart; p 197
  • 6 Denson KW E. 1978; Thromboplastin generation. Lancet 1: 718
  • 7 Hills M, Ingram GI C. 1973; Monitoring successive batches of British Comparative Thromboplastin. British Journal of Haematology 25: 445
  • 8 ICTH/ICSH. 1979; Prothrombin time standardization. Report of the Expert Panel on Oral Anticoagulant Control. The International Committee on Thrombosis and Haemostasis. The International Committee for Standardization in Hematology Thrombosis and Haemostasis 1073
  • 9 Loeliger EA, Halem-Visser LP van. 1979; Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization. Thrombosis and Haemostasis 1115
  • 10 Miale JB, Kent JW. 1973; Performance characteristics of reference thromboplastins. American Journal of Clinical Pathology 60: 453
  • 11 Murphy EA, Denson KW E. 1970. Statistical analysis of experiments performed in connection with thromboplastin standardization. Proceedings of the International Committee on Thrombosis and Haemostasis, Princetown, U. S. A. 1968 p. 377 F. K. Schattauer Verlag, Stuttgart; New York: 1970
  • 12 Owren PA. 1959; Thrombotest. A new method for controlling anticoagulant therapy. Lancet 2: 754
  • 13 Poller L, Ingram GI C. 1975. Standardization and quality control of anticoagulant control. In: Lewis SM, Coster JF. (eds.) Quality Control in Heamatology. Academic Press; London - New York: p 160
  • 14 Poller L, Thomson JM, Yee KF. 1977; Stability studies on lyophilised reference thromboplastins for standardisation of prothrombin times. Lancet 2: 1019
  • 15 Poller L, Thomson JM, Yee KF. 1978; Stability of reference thromboplastins. Lancet 1: 151
  • Quick AJ. 1935; The prothrombin in hemophilia and in obstructive jaundice. Journal of Biological Chemistry 109: 73
  • 17 WHO. 1977; Expert Committee on Biological Standardization. 28th Report Technical Report Series, World Health Organization No. 610 p 48